At CRF Health we understand the importance of therapeutic experience when selecting an ePRO partner. With decades of experience in Phases I through IV drug development we have the most comprehensive therapeutic area experience, with an average compliance rate across studies of 90% and experience in over 45 indications including:
Vaccine Studies
CRF Health is a leader in the use of ePRO in vaccine studies, having conducted 33 vaccine trials in 35 countries and in 17 languages. We have logistics and delivery centers in the US and Europe, assuring timely and efficient support for global studies.
Asthma & Respiratory Studies
Successful asthma and respiratory studies depends on experience-driven, sympathetic diary design. CRF Health is the only eDiary provider to have a validated gold standard AQLQ instrument on both landline and wireless devices.
Pain Studies
CRF Health has extensive experience with acute and chronic pain studies, having conducted 33 trials, with more than 180,000 ePRO patients enrolled. With less than 2% of over 33 million data items subject to data change requests and an average adult patient compliance rate of 90% with eDiaries, CRF Health has had great success in this area.
|
